WILLIAM WONG to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications WILLIAM WONG has written about Randomized Controlled Trials as Topic.
Connection Strength
0.183
-
Antiviral treatment for treatment-na?ve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2019 08 19; 8(1):207.
Score: 0.111
-
Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time. J Oncol Pract. 2018 05; 14(5):e280-e294.
Score: 0.025
-
A randomized study of dietary composition during weight-loss maintenance: Rationale, study design, intervention, and assessment. Contemp Clin Trials. 2018 02; 65:76-86.
Score: 0.025
-
Cost-Effectiveness Analysis of Different Sequences of the Use of Epidermal Growth Factor Receptor Inhibitors for Wild-Type KRAS Unresectable Metastatic Colorectal Cancer. J Oncol Pract. 2016 06; 12(6):e710-23.
Score: 0.022